Restricted access

Abstract

First published online June, 2001

FIRST KNOWN REPORTED CASE OF ALLERGIC CONTACT DERMATITIS TO LATANOPROST,THE ACTIVE INGREDIENT IN XALATAN OPHTHALMIC SOLUTION: 6